- Darren Carroll
- Director
- Thomas Grein
- President
- Jonathan Haug
- Vice President
ICOS is discovering and developing breakthrough, proprietary products with high commercial potential for the treatment of serious medical diseases. We've spent more than a decade building a highly credible, committed research and development team. Today, with the availability of Cialisin global markets, and with product candidates moving through the product pipeline, we are strategically poised to become a strong and successful commercial organization.ICOS is a Bothell, Washington-based company that began operations in 1990. Many of the initial 65 staff members are still part of the approximately 675 people in the ICOS community. ICOS is dedicated to bringing novel and effective drugs to market that meet significant unmet medical needs, and can increase the quality of life for millions of people.